IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement

Affiliations

• ¹ Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.
• ² Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway.
• ³ Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; Thrombosis Research Center (TREC), Division of internal medicine, University hospital of North Norway, Tromsø Norway.
• ⁴ Department of Internal Medicine, Bærum Hospital, Vestre Viken Hospital Trust, 1346 Gjettum, Norway; Division of Laboratory Medicine, Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.
• ⁵ Department of Hematology, Oslo University Hospital, Oslo, Norway; Hospital Pharmacies, South-Eastern Norway Enterprise, Oslo, Norway.
• ⁶ Department of Anaesthesia and Intensive Care Medicine, Oslo University Hospital, Oslo, Norway.
• ⁷ Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; Department of Infectious Diseases, Oslo University Hospital, Ullevål, Oslo, Norway.
• ⁸ Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
• ⁹ Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
• ¹⁰ Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway. Electronic address: ida.gregersen@medisin.uio.no.